Is GSK or MDT cheaper?

On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and MDT at 21.71.

Which has grown faster, GSK or MDT?

Over the past five years, MDT grew revenue faster — GSK at a 0.63% CAGR versus MDT at 5.18%.

Does GSK or MDT pay a bigger dividend?

GSK yields 3.51% and MDT yields 3.56% based on trailing dividends and the latest price.

Is GSK or MDT more profitable?

GSK runs the higher net margin — GSK at 17.76% versus MDT at 13.20%.

Which has been the better investment, GSK or MDT?

Over the past 10-year, GSK delivered the higher annualized total return — GSK at 7.50% versus MDT at 2.46%. Past performance doesn't predict future results.

GSK plc (GSK) vs Medtronic plc (MDT)

GSK leads on 12 of 16 compared metrics.

A side-by-side comparison of GSK plc and Medtronic plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — GSK vs MDT

growth of $100 · last 30y

GSK +98.1%MDT +482.2%MDT compounded faster

GSK MDT

GSK vs MDT: by the numbers

•GSK is the larger company ($105.20B vs $103.66B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 21.71 P/E).
•GSK converts more revenue to profit (17.76% vs 13.20% net margin).
•MDT grew revenue faster over the past five years (5.18% vs 0.63% CAGR).
•MDT pays the higher dividend yield (3.56% vs 3.51%).

Which is better, GSK or MDT?

Metric tally: GSK 12 · MDT 4

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthMDT(faster 5Y revenue CAGR)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	GSK	MDT
P/E ratio	11.62●	21.71
Forward P/E	13.25	12.67●
P/S ratio	2.42●	2.87
P/B ratio	3.44	2.11●
PEG ratio	0.02●	6.72
EV / EBITDA	8.62●	13.96
FCF yield	7.87%●	5.20%

Profitability

Metric	GSK	MDT
Gross margin	72.67%●	65.02%
Operating margin	25.65%●	17.78%
Net margin	17.76%●	13.20%
ROE	25.19%●	9.70%
ROIC	16.61%●	6.13%

Dividends

Metric	GSK	MDT
Dividend yield	3.51%	3.56%
Payout ratio	24.30%	76.80%

Growth (annualized)

Metric	GSK	MDT
Revenue CAGR (5Y)	0.63%	5.18%●
EPS CAGR (5Y)	14.05%●	0.83%
FCF CAGR (5Y)	-0.35%	3.07%●
Total return CAGR (5Y)	10.18%●	-5.39%

Frequently asked

Which is better, GSK or MDT?: It depends on your goal. value: GSK (lower P/E); growth: MDT (faster 5Y revenue CAGR); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 12 to 4.
Is GSK or MDT cheaper?: On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and MDT at 21.71.
Which has grown faster, GSK or MDT?: Over the past five years, MDT grew revenue faster — GSK at a 0.63% CAGR versus MDT at 5.18%.
Does GSK or MDT pay a bigger dividend?: GSK yields 3.51% and MDT yields 3.56% based on trailing dividends and the latest price.
Is GSK or MDT more profitable?: GSK runs the higher net margin — GSK at 17.76% versus MDT at 13.20%.
Which has been the better investment, GSK or MDT?: Over the past 10-year, GSK delivered the higher annualized total return — GSK at 7.50% versus MDT at 2.46%. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full MDT analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio Medtronic P/E ratio GSK dividend yield Medtronic dividend yield GSK ROE Medtronic ROE GSK operating margin Medtronic operating margin GSK revenue growth Medtronic revenue growth GSK free cash flow Medtronic free cash flow

GSK & Medtronic appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.